###begin article-title 0
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 88 88 88 88 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 88 88 88 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 88 88 88 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
Increased Protein Stability of FGF1 Can Compensate for Its Reduced Affinity for Heparin*
###end article-title 0
###begin p 1
Fellow of the Research Council of Norway.
###end p 1
###begin p 2
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human FGF1 (fibroblast growth factor 1) is a powerful signaling molecule with a short half-life in vivo and a denaturation temperature close to physiological. Binding to heparin increases the stability of FGF1 and is believed to be important in the formation of FGF1.fibroblast growth factor receptor (FGFR) active complex. In order to reveal the function of heparin in FGF1.FGFR complex formation and signaling, we constructed several FGF1 variants with reduced affinity for heparin and with diverse stability. We determined their biophysical properties and biological activities as well as their ability to translocate across cellular membranes. Our study showed that increased thermodynamic stability of FGF1 nicely compensates for decreased binding of heparin in FGFR activation, induction of DNA synthesis, and cell proliferation. By stepwise introduction of stabilizing mutations into the K118E (K132E) FGF1 variant that shows reduced affinity for heparin and is inactive in stimulation of DNA synthesis, we were able to restore the full mitogenic activity of this mutant. Our results indicate that the main role of heparin in FGF-induced signaling is to protect this naturally unstable protein against heat and/or proteolytic degradation and that heparin is not essential for a direct FGF1-FGFR interaction and receptor activation.
###end p 2
###begin p 3
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 613 614 613 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 638 639 638 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 638 639 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN4"><sup>3</sup></xref>
###xml 838 839 830 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 98 104 <span type="species:ncbi:9606">humans</span>
FGF1 (fibroblast growth factor 1) belongs to a family of polypeptide growth factors comprising in humans 22 structurally related proteins (1, 2). The signaling induced by the growth factor leads to a wide range of cellular responses during development as well as in adult life, such as growth regulation, differentiation, survival, stress response, migration, and proliferation of different cell types (3). The biological activity of FGF1 is exerted through binding to four high affinity cell surface receptors (FGFR1-4), resulting in receptor dimerization and transphosphorylation in its tyrosine kinase domain (4, 5). The activated FGFR3 induces cellular response by initiating several signaling cascades, including mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase/Akt, and phospholipase C-gamma (PLC-gamma) pathways (6).
###end p 3
###begin p 4
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 295 296 295 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
In addition to FGFRs, FGF1 binds to heparan sulfates (HS) associated with proteoglycans at the cell surface and in the extracellular matrix (7). Among the physiological sugars, the highest affinity for FGF1 is shown by heparin, a widely used linear, highly sulfated polysaccharide composed of 2-O-sulfated iduronic acid and 6-O-sulfated, N-sulfated glucosamine units (8).
###end p 4
###begin p 5
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 574 575 574 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 577 578 577 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 578 578 578 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9"/>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Despite many years of research, there is still controversy regarding the molecular role of heparin/HS in FGF1- and FGF2-induced signaling. Thus, the question of whether or not the linkage of two molecules of the growth factor by heparin/HS is an absolute prerequisite for induction of FGFR dimerization is still open. Numerous studies have concluded that the presence of heparin/HS is obligatory for FGF signaling. It is widely believed that heparin/HS is directly involved in receptor dimerization and is critical for mitogenic response stimulated by the growth factor (4, 6, 8-10).
###end p 5
###begin p 6
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 514 514 514 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13"/>
###xml 514 514 514 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14"/>
###xml 514 514 514 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15"/>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
On the other hand, several authors working on FGF1 and FGF2 have suggested that there is no mandatory requirement for heparin for the assembly and activation of the FGF.FGFR complex. They imply that heparin only plays a role in association of two molecules of the growth factor and therefore facilitates their binding to FGFR (11). It has been reported that FGF1 and FGF2 can interact with the FGFR and trigger phosphorylation of p42/44 MAPK and activation of other signaling pathways even in the absence of HS (12-16).
###end p 6
###begin p 7
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The accepted role of heparin/HS in FGF1 signaling is to prevent the degradation of the growth factor (17). The interaction with heparin or HS protects FGF1 against heat, acidic pH, and proteases (18, 19). HS also seems to regulate the activity of different FGFs by creating their local reservoir and generating a concentration gradient of the growth factor (6, 17).
###end p 7
###begin p 8
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 172 175 172 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
###xml 180 183 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 275 278 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">122</sup>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 399 402 399 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">113</sup>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">119</sup>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">128</sup>
###xml 440 442 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 447 450 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">114</sup>
###xml 459 462 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">127</sup>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 552 555 552 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 825 827 825 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 829 831 829 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
The binding of FGF1 to heparin/HS is mediated by specific residues forming a positively charged patch on the protein surface (20, 21). The major contribution is made by Lys118 (Lys132 in the full-length numbering system), which was identified by Harper and Lobb (22), and Lys112 and Arg122 (23, 24). Additional residues of FGF1 involved in the interaction with heparin are the positively charged Lys113, Arg119, and Lys128 and the polar Asn18, Asn114, and Gln127 (20, 21). Site-directed mutagenesis and other studies have revealed the importance of Lys118 not only in heparin binding but also for the biological function of FGF1 (22, 25, 26). It was shown that the K118E (K132E) mutant is inactive in stimulation of DNA synthesis, although its affinity for FGFR and the ability to activate signaling cascades is not reduced (27, 28). Despite extensive research, the reason for the lack of mitogenic potential of K118E FGF1 is still not clear.
###end p 8
###begin p 9
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 434 434 434 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31"/>
###xml 434 434 434 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32"/>
###xml 434 434 434 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33"/>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
In this paper, we verified the function of heparin in FGF1.FGFR complex formation and signaling by constructing several FGF1 mutants with reduced affinity for heparin. To recover the stability of these variants, which could no longer be stabilized by heparin, we supplemented them stepwise with stabilizing mutations (29). We analyzed thoroughly their biological activity and their ability to translocate across cellular membranes (30-34). Interestingly, the full mitogenic activity of the K118E FGF1 variant was restored by the introduced stabilizing mutations.
###end p 9
###begin p 10
Our results indicate that the main role of heparin in FGF-induced signaling is to protect this naturally unstable protein against heat denaturation and proteolytic degradation and that the increased stability of the growth factor can compensate for reduced heparin binding.
###end p 10
###begin title 11
EXPERIMENTAL PROCEDURES
###end title 11
###begin title 12

###end title 12
###begin title 13

###end title 13
###begin title 14
Materials
###end title 14
###begin p 15
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 116 132 116 132 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">Escherichia coli</named-content>
###xml 414 420 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">methyl</italic>
###xml 421 422 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 439 441 439 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 498 501 498 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 116 144 <span type="species:ncbi:511693">Escherichia coli strain BL21</span>
###xml 782 788 <span type="species:ncbi:9986">rabbit</span>
###xml 815 820 <span type="species:ncbi:10090">mouse</span>
###xml 833 839 <span type="species:ncbi:9986">rabbit</span>
###xml 847 853 <span type="species:ncbi:9986">rabbit</span>
###xml 869 875 <span type="species:ncbi:9986">rabbit</span>
###xml 889 895 <span type="species:ncbi:9986">rabbit</span>
###xml 904 910 <span type="species:ncbi:9986">rabbit</span>
###xml 931 936 <span type="species:ncbi:10090">mouse</span>
###xml 999 1005 <span type="species:ncbi:9986">rabbit</span>
###xml 1019 1023 <span type="species:ncbi:9925">goat</span>
###xml 1153 1158 <span type="species:ncbi:10090">mouse</span>
###xml 1197 1202 <span type="species:ncbi:9606">Human</span>
###xml 1263 1274 <span type="species:ncbi:3704">Horseradish</span>
The site-directed mutagenesis kit (QuikChangeTM) was from Stratagene, and the DNA purification kit was from Qiagen. Escherichia coli strain BL21(DE3)pLysS was from New England Biolabs. Heparin-Sepharose CL-6B affinity resin was from Amersham Biosciences, and oligonucleotides for mutagenesis were from Sigma. The basic components of culture media were supplied by Merck, and guanidine hydrochloride was from ICN. [methyl-3H]Thymidine and [33P]phosphate were provided by Amersham Biosciences, and Na125I was from PerkinElmer Life Sciences. Complete protease inhibitor mixture was from Roche Applied Science. Phosphatase inhibitor mixture, lactacystin chloroquine, and trypsin were from Sigma, and bafilomycin A1 and leupeptin were from Calbiochem. Antibodies against MAPK (p42/p44) (rabbit), phospho-MAPK (p42/p44) (mouse), p38 MAPK (rabbit), Akt (rabbit), phospho-Akt (rabbit), PLC-gamma (rabbit), FGFR (rabbit), and phospho-FGFR (mouse) were from Cell Signaling Technology. Anti-phospho-PLC-gamma (rabbit), anti-FGF1 (goat), and anti-phospho-Tyr antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and anti-phospho-p38 MAPK antibody (mouse) was from BD Transduction Laboratory. Human antibody against EEA1 was a kind gift from Harald Stenmark. Horseradish peroxidase-conjugated and fluorescent secondary antibodies were from Jackson ImmunoResearch Laboratories. All other chemicals were from Sigma.
###end p 15
###begin title 16
Cell Cultures
###end title 16
###begin p 17
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 214 220 <span type="species:ncbi:9913">bovine</span>
###xml 394 398 <span type="species:ncbi:9913">calf</span>
The NIH 3T3 cell line was obtained from ATCC. U2OS stably transfected with FGFR1 was a kind gift from Ellen M. Haugsten (35). NIH 3T3 cells were grown in Quantum 333 medium from PAA Laboratories GmbH containing 2% bovine serum (Invitrogen) and 100 units/ml penicillin and 100 mug/ml streptomycin. U2OS cells were grown in Dulbecco's modified Eagle's medium from Invitrogen containing 10% fetal calf serum (PAA Laboratories). Cells were seeded into tissue culture plates the day preceding the start of the experiments.
###end p 17
###begin title 18
Protein Production and Purification
###end title 18
###begin p 19
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 262 263 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 403 410 397 404 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="genus-species">E. coli</named-content>
###xml 487 489 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 965 967 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 403 415 <span type="species:ncbi:511693">E. coli BL21</span>
A construct comprising a truncated form (residues 21-154) of human FGF1 in the pET-3c vector was used. Mutagenesis and protein expression were performed as reported previously (29, 34, 36). In the case of mutants with significantly reduced heparin binding, a His6 tag was introduced at the N terminus of the protein to allow efficient purification. Recombinant proteins were expressed at 37 degreesC in E. coli BL21(DE3)pLysS strain and purified on a heparin-Sepharose CL-6B column or Ni2+-nitrilotriacetic acid column, followed by size exclusion chromatography on Superdex-75 using AKTA Explorer system (Amersham Biosciences). Protein purity was confirmed by silver-stained SDS-PAGE, and molecular masses were verified by electrospray ionization mass spectrometry. Native conformation of the variants was confirmed by circular dichroism and fluorescence spectra measurements. The numbering system used to identify amino acids in FGF1 has been reported previously (36).
###end p 19
###begin title 20
Thermodynamic Studies
###end title 20
###begin p 21
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 291 292 291 292 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
To analyze thermodynamic properties of the recombinant proteins we employed CD and fluorescence (29). To prevent both protein aggregation and accumulation of folding intermediates during heating, thermal denaturation was performed in the presence of a low concentration of a denaturant, 0.7 m guanidinium chloride, in phosphate buffer (37). The temperature-induced ellipticity changes at 227 nm were followed in cuvettes of 10-mm path length using an 8-s response time. Denaturation performed in the spectrofluorimeter was monitored by changes in fluorescence intensity at 353 nm of the single tryptophan residue of FGF1 excited at 280 nm (38). All denaturation data, irrespective of the method, were collected using a scan rate of 0.25 degreesC/min.
###end p 21
###begin p 22
###xml 270 271 270 271 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 296 297 296 297 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
To analyze the impact of heparin on thermal denaturation of FGF1, we performed denaturation of the wild type and the mutants using the CD technique in the absence and presence of a 5-fold molar excess of heparin. The measurements were carried out in the presence of 1.5 m urea (equivalent of 0.7 m guanidinium chloride), which is a non-ionic denaturant and does not disturb the ionic interactions between heparin and growth factor (29).
###end p 22
###begin p 23
###xml 36 38 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 38 39 38 39 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
The protein concentration was 2 x 10-6m in all thermodynamic experiments. The data were analyzed using PeakFit software (Jandel Scientific Software), assuming a two-state reversible equilibrium transition, as described previously (29, 36).
###end p 23
###begin title 24
Receptor Binding Assay
###end title 24
###begin p 25
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 671 672 665 666 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 795 796 789 790 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 873 876 867 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
Binding of FGF1 to cell surface receptors was analyzed essentially as published (29, 34, 39). Wild type FGF1 in high salt buffer was dialyzed against PBS and iodinated using the Iodogen method. The labeled growth factor was then purified on a disposable PD-10 desalting column (Amersham Biosciences). Confluent NIH 3T3 cells were washed with ice-cold binding buffer (HEPES medium, 10 units/ml heparin) and incubated with 6 ng/ml 125I-labeled FGF1 and increasing concentrations of unlabeled FGF1 or its mutants for 3 h at 4 degreesC. Subsequently, the cells were washed twice with ice-cold binding buffer and once with ice-cold PBS, followed by the addition of ice-cold 1 m NaCl in PBS to dissociate the growth factor from heparans at the cell surface. After washing, the cells were lysed in 0.1 m KOH, and the solubilized radioactivity, representing the cell surface-bound 125I-FGF1, was measured with a gamma-counter.
###end p 25
###begin title 26
Microscopy
###end title 26
###begin p 27
###xml 330 335 <span type="species:ncbi:10090">mouse</span>
###xml 401 406 <span type="species:ncbi:9606">human</span>
Serum-starved U2OS cells stably transfected with FGFR1 were incubated with 100 ng/ml selected FGF1 mutants for 15 min at 37 degreesC in the presence or absence of heparin (10 units/ml). The cells were then washed with PBS and fixed with 10% formalin solution (Sigma), permeabilized with 0.1% Triton X-100 in PBS, and stained with mouse anti-phospho-tyrosine antibody labeling the phosphorylated FGFR, human anti-EEA1 antibody (a specific marker for early endosomes), and DRAQ5 (a nuclear probe from Alexis Biochemicals). Finally, the cells were incubated with fluorescent secondary antibodies. The cells were examined with a Zeiss LSM Duo confocal microscope. Images of randomly chosen cells were taken.
###end p 27
###begin title 28
Activation of Signaling Pathways
###end title 28
###begin p 29
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
To detect phosphorylated forms of downstream signaling proteins, serum-starved NIH 3T3 cells were stimulated for 15 min with 5 and 50 ng/ml growth factor in the presence or absence of heparin (10 units/ml). The cells were lysed with SDS sample buffer, scraped from the plate, and sonicated. Total cell lysates were separated by SDS-PAGE, transferred onto Immobilon-P membrane, and subjected to immunoblot analysis for phosphorylated (activated) forms of the respective signaling proteins (29). After stripping, the membrane was reprobed with antibodies against total signaling proteins to ensure equal loading.
###end p 29
###begin title 30
Measurements of DNA Synthesis
###end title 30
###begin p 31
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 426 427 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 552 553 539 540 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 707 708 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 919 921 903 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 226 232 <span type="species:ncbi:9913">bovine</span>
The mitogenic properties of FGF1 mutants were assessed by monitoring [3H]thymidine incorporation in response to the stimulation of NIH 3T3 cells (27, 29). The cells were starved in Dulbecco's modified Eagle's medium with 0.5% bovine serum for 24 h at 37 degreesC. Then increasing amounts (0.1-100 ng/ml) of FGF1 or its mutants were added, and the incubation was continued for 24 h at 37 degreesC. For the last 6 h, 1 muCi/ml [3H]thymidine was added to the cells. Finally, the cells were treated with 5% trichloroacetic acid and then solubilized in 0.1 m KOH, and the level of trichloroacetic acid-insoluble radioactivity was measured using a liquid scintillation beta-counter. The relationship between the [3H]thymidine incorporation and log concentration of the added growth factor was fitted to a sigmoidal function. Specific mitogenic activity was expressed as the concentration giving 50% of maximal stimulation (EC50).
###end p 31
###begin title 32
Proliferation Assay
###end title 32
###begin p 33
Serum-starved NIH 3T3 cells were treated with 100 ng/ml wild type or mutant FGF1 in the presence or absence of heparin (10 units/ml) for 72 h and then counted.
###end p 33
###begin title 34
Protease Digestion Assay
###end title 34
###begin p 35
###xml 177 178 171 172 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 189 190 183 184 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Digestion experiments were carried out at 37 degreesC by incubation of the wild type and mutants of FGF1 within trypsin at 1:80 and 1:20 molar ratios in a reaction buffer (100 mm Tris, 20 mm calcium chloride, pH 8.3). The proteolysis was stopped by the addition of SDS sample buffer. Products of the reaction were visualized by SDS-PAGE and Coomassie Blue staining.
###end p 35
###begin title 36
In Vivo FGF1 Degradation Assay
###end title 36
###begin p 37
###xml 332 333 332 333 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 354 355 353 354 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 374 375 372 373 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 380 381 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 389 390 387 388 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 414 415 411 412 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Serum-starved NIH 3T3 cells were incubated with 10 ng/ml wild type or mutants of FGF1, in the presence or absence of heparin, for up to 24 h. Additionally, cells were incubated with 10 ng/ml wild type of FGF1 in the absence of heparin with or without pre-exposure for 30 min to lysosomal degradation inhibitors: bafilomycin A1 (10 nm), chloroquine (25 mum), leupeptin (30 mum), NH4Cl (20 mm), or lactacystin (10 mum), a proteasome inhibitor. Then the medium was removed, and the cells were lysed in lysis buffer at time points 0.1, 6, 9, 12, and 24 h. Lysates and medium fractions were adsorbed onto heparin-Sepharose or subjected to trichloroacetic acid precipitation. The amount of intact growth factor in the samples was analyzed by SDS-PAGE and immunoblotting using anti-FGF1 antibody.
###end p 37
###begin title 38
In Vivo Phosphorylation of Externally Added FGF1
###end title 38
###begin p 39
###xml 219 221 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 446 447 445 446 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 458 459 457 458 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 462 463 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 466 467 465 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 489 490 488 489 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 997 999 989 991 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 82 88 <span type="species:ncbi:9913">bovine</span>
NIH 3T3 cells were starved for 24 h in Dulbecco's modified Eagle's medium with 1% bovine serum. Then the cells were incubated overnight in phosphate-free Dulbecco's modified Eagle's medium supplemented with 25 muCi/ml [33P]phosphate. Next the cells were treated with 10 units/ml heparin and 100 ng/ml recombinant FGF1 for 6 h. Subsequently, the cells were washed once with PBS containing phosphatase inhibitor mixture, lysed in lysis buffer (0.1 m NaCl, 10 mm Na2HPO4, 1% Triton X-100, 1 mm EDTA) supplemented with protease and phosphatase inhibitor mixtures, scraped, and sonicated. The lysates were adsorbed onto heparin-Sepharose for 2 h at 4 degreesC. To reduce the background, the beads were treated with 2 mug/ml tosylphenylalanyl chloromethyl ketone-treated trypsin for 30 min at room temperature. Finally, samples were subjected to SDS-PAGE, transferred onto Immobilon-P membrane (Millipore), and analyzed by immunoblotting (to detect the total amount of FGF1) and fluorography (to detect 33P-phosphorylated FGF1).
###end p 39
###begin title 40
Digitonin Cell Fractionation
###end title 40
###begin p 41
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 743 744 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Cell fractionation was essentially performed as previously described (40). NIH 3T3 cells were starved for 24 h and then incubated with wild type FGF1 or different FGF1 mutants in the presence or absence of heparin for 6 h at 37 degreesC and washed with high salt/low pH buffer to remove FGF1 bound to the cell surface. The cells were then washed with PBS, and 20 mug/ml digitonin was added to permeabilize the cells. The cells were kept at room temperature for 5 min and on ice for an additional 30 min to allow the cytosol to leak into the buffer. Then the cells were scraped from the plastic and centrifuged. The supernatant was designated as the cytosol fraction. The cellular pellet was lysed with lysis buffer and centrifuged at 15,800 x g for 15 min. The supernatant was designated as the membrane fraction, and the nuclear pellet was sonicated in lysis buffer and centrifuged as above. The final supernatant was designated as the nuclear fraction. Growth factor from all fractions was precipitated with 50% trichloroacetic acid and solubilized in sample buffer. The samples were analyzed by SDS-PAGE and immunoblotting with FGF1-specific antibodies.
###end p 41
###begin title 42
RESULTS
###end title 42
###begin title 43
Preparation and Biophysical Properties of FGF1 Mutants
###end title 43
###begin title 44

###end title 44
###begin title 45
Design and Expression of FGF1 Mutants
###end title 45
###begin p 46
###xml 21 23 21 23 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 728 730 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 834 837 834 837 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
###xml 845 848 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">126</sup>
###xml 924 927 924 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">132</sup>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1027 1033 1027 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
In a previous study (29), we showed that increased stability of FGF1 can prolong its half-life, increase protease resistance, and enhance the biological activities of the growth factor. Our results suggested that stabilizing mutations can compensate for the absence of heparin and allow full mitogenic activity of FGF1 in NIH 3T3 cells. To elucidate the significance of heparin in activation of the FGF1.FGFR complex and in FGF1-induced signaling, we constructed a series of 17 variants (six single, one double, and 10 multiple mutants) with reduced affinity for heparin/HS and with different stability (). The mutations were designed based on the crystal structure of the FGF.FGFR complex (41, 42) and on our previous studies (29). Two crucial residues involved in heparin binding by the growth factor were selected for mutation (Lys112 and Lys118 in the 140-amino acid numbering system (38) corresponding to Lys126 and Lys132 in the full-length numbering system) and three residues known to stabilize the FGF1 molecule (29) (Fig. 1). All mutant proteins were expressed in the pET3c/BL21(DE3)pLysS system with a yield of 20-40 mg of pure protein/1 liter of culture.
###end p 46
###begin p 47
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spatial structure of FGF1 (Protein Data Bank code <ext-link ext-link-type="pdb" xlink:href="1rg8">1rg8</ext-link>).</bold>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">magenta</italic>
Spatial structure of FGF1 (Protein Data Bank code ). Amino acid residues mutated to lower FGF1 affinity for heparin and to increase its stability are marked in red and magenta, respectively.
###end p 47
###begin title 48
Biophysical Characteristics of FGF1 Mutants
###end title 48
###begin p 49
###xml 506 512 506 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 601 604 601 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
###xml 615 618 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
###xml 818 819 818 819 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 877 878 877 878 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 929 930 929 930 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 1039 1042 1039 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
Native conformation of the FGF1 variants was confirmed by CD and fluorescence. There were no significant changes in fluorescence and in far- and near-CD spectra of the mutants as compared with the wild type growth factor, suggesting that the secondary and tertiary structures were preserved (data not shown). However, due to the lysine substitutions, individual mutants differed significantly in their affinity for heparin, as tested by elution from a heparin-Sepharose column with a linear NaCl gradient. Fig. 2 shows elution profiles of the six single and one double mutant with substitutions of Lys112 or/and Lys118 from the heparin-Sepharose column. Due to a reduced affinity for immobilized heparin, all variants were eluted at lower salt concentrations compared with the wild type FGF1, which was eluted at 1.33 m NaCl. The elution peak for the K118E variant was at 0.45 m NaCl, whereas the K112N mutant was eluted at 0.67 m. Mutations at position 112 reduced the affinity for heparin to a lesser extent than the substitutions of Lys118. Furthermore, mutations to alanine were less effective in lowering the heparin binding ability of FGF1 than the substitutions to asparagine and glutamic acid at the same positions.
###end p 49
###begin p 50
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Elution profiles of FGF1 and its mutants from a heparin-Sepharose column.</bold>
Elution profiles of FGF1 and its mutants from a heparin-Sepharose column.
###end p 50
###begin p 51
###xml 129 130 129 130 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
In the case of the double lysine mutant (K112N/K118E), the affinity for heparin was very low, and the protein was eluted at 0.25 m NaCl. Because the heparan sulfates found on the cell surface are less sulfated than heparin, this mutant presumably does not exhibit any affinity for HS at physiological salt concentrations. The elution profiles of multiple mutants containing the K112N or/and K118E mutation and the stabilizing substitutions were the same as for the lysine mutants alone (data not shown).
###end p 51
###begin title 52
Thermodynamic Stability of FGF1 Mutants
###end title 52
###begin p 53
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 162 165 162 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 206 207 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 207 210 203 206 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 468 469 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 469 472 465 468 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 515 516 511 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 516 519 512 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 544 550 540 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 550 551 546 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
To measure accurately the conformational stability of the different FGF1 constructs, we employed thermal denaturation.  summarizes the denaturation temperature (Tden) and the van't Hoff enthalpy data (DeltaHden) obtained from denaturation experiments monitored by CD and fluorescence. The data demonstrate very good agreement between the two methods applied. The effects of the mutations on the conformational stability of FGF1 can be easily assessed by comparing the Tden values of the respective variant with the Tden value of the wild type (Fig. 3A). Since very similar values were obtained for both measurement techniques, we discuss only the thermodynamic parameters based on the CD data.
###end p 53
###begin p 54
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Thermal stability of FGF1 mutants.</bold>
###xml 34 35 34 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 117 118 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 118 121 114 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 124 125 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 125 128 121 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 131 132 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 132 135 128 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 213 214 209 210 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 237 238 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 337 338 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 338 341 330 333 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 341 348 333 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">heparin</sup>
###xml 351 352 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 352 355 344 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 355 363 347 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+heparin</sup>
###xml 366 367 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 367 370 359 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 370 378 362 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;heparin</sup>
###xml 435 436 427 428 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
Thermal stability of FGF1 mutants.A, changes in denaturation temperature between the mutants and the wild type (DeltaTden = Tden - Tden(WT)) monitored by fluorescence and circular dichroism in the presence of 0.7 m guanidinium chloride. B, changes in denaturation temperature of FGF1 mutants in the presence and absence of heparin (DeltaTdenheparin = Tden+heparin - Tden-heparin) monitored by circular dichroism in the presence of 1.5 m urea.
###end p 54
###begin p 55
###xml 648 649 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 649 652 633 636 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 745 751 723 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 751 752 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
The single mutants, with the exception of K112N and K118N, exhibited slightly lower thermal stability than the wild type. Introduction of the K112N substitution caused a marked increase of the denaturation temperature, by more than 3 degreesC. A similar replacement of Lys at position 118 (K118N) resulted in a strong reduction of the thermal stability of FGF1 by 12 degreesC. The double mutant K112N/K118E, containing the most thermodynamically favorable lysine mutation, K112N, and the mutation resulting in the lowest heparin affinity among the single mutants, K118E, exhibited a slightly elevated stability as compared with the wild type (DeltaTden = 1.5 degreesC). The effects of these two point mutations sum up in the double mutant ( and Fig. 3A).
###end p 55
###begin p 56
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 489 490 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 490 493 490 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 724 725 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 725 728 719 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 823 829 811 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 829 830 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
In this study, we made use of three previously described FGF1-stabilizing mutations, Q40P, S47I, and H93G (which did not affect any functional properties of the growth factor and stabilized it to the largest extent), and combined them with the substitutions that reduced the affinity of the growth factor to heparin in 10 multiple variants (29, 43). The introduction of the double stabilizing substitution (Q40P/S47I, denoted 2x) to the K112N, K118E, and K112N/K118E mutants increased the Tden of FGF1 by 18.2, 14.9, and 16.7 degreesC, respectively. Further, combination of all three stabilizing mutations (Q40P/S47I/H93G, denoted 3x) with the lysine substitutions yielded quadruple or quintuple mutants with an increase in Tden between 20.9 and 23.8 degreesC, thus providing a dramatic increase in thermal stability ( and Fig. 3A).
###end p 56
###begin p 57
###xml 406 407 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 407 410 403 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 410 417 406 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">heparin</sup>
###xml 420 421 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 421 424 417 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 424 432 420 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+heparin</sup>
###xml 435 436 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 436 439 432 435 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 439 447 435 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;heparin</sup>
###xml 455 461 451 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 461 462 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 796 797 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 797 800 783 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 800 807 786 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">heparin</sup>
###xml 814 820 800 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 820 821 806 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 902 903 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 903 906 885 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 906 913 888 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">heparin</sup>
To test how the substitutions of lysines at position 112 and 118 influence the protective effect of heparin, we performed thermal unfolding of FGF1 and its mutants in the presence or absence of a 5-fold molar excess of heparin monitored by circular dichroism. To present the differences between the mutants, we calculated the change in denaturation temperature in the presence and absence of heparin (DeltaTdenheparin = Tden+heparin - Tden-heparin) ( and Fig. 3B). Heparin stabilized the wild type FGF1 by 13.4 degreesC. Similar values were obtained for many other FGF1 mutants, available in the laboratory, with undisturbed affinity for heparin (data not shown). However, for all mutants with a decreased affinity for heparin presented in this study, we observed a significant reduction in DeltaTdenheparin ( and Fig. 3B). Mutant K112N and all variants that contained this substitution exhibited DeltaTdenheparin around 3.5 degreesC. Opposite charge substitutions, such as K112E and K118E, even caused a slight destabilization of the protein in the presence of heparin. For all the variants that carried the K118E mutation, the addition of heparin decreased the protein stability by close to 3 degreesC. In the case of the variants with double lysine substitutions (K112N/K118E), we observed a decrease in denaturation temperature in the presence of heparin in the range of 4-6.1 degreesC. These results confirmed that the selected lysine mutations strongly influenced the ability of FGF1 to bind properly to heparin and abolished its protective effect.
###end p 57
###begin title 58
Biological Properties of FGF1 Mutants
###end title 58
###begin title 59

###end title 59
###begin title 60
Binding of the FGF1 Mutants to FGFR and Their Ability to Induce Its Activation
###end title 60
###begin p 61
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 825 828 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
Using a competitive binding assay with 125I-labeled wild type FGF1, we tested the ability of the mutants to bind specifically to FGFRs in NIH 3T3 cells, which express mainly FGFR1, and displace the labeled FGF1 from the receptors. None of the single lysine substitutions that reduced the affinity of FGF1 for heparin altered the affinity of the growth factor for the receptor, since there were no differences in the ability of the mutants to compete with the wild type [125I]FGF1 (). This indicates that neither of the mutated residues is involved in the interactions with the high affinity receptor. However, variants containing the K112N/K118E double substitution were slightly less effective in competing out the labeled wild type FGF1. This discrepancy can be explained by the conditions of the experiment. For efficient 125I-labeling of FGF1, the presence of heparin is required, which causes effective dimerization of the growth factor in solution. Therefore, during the course of the experiment, the kinetics of receptor binding favors the dimerized labeled wild type FGF1 over the monomeric mutants with strongly reduced ability to bind free heparin.
###end p 61
###begin p 62
###xml 413 416 413 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 572 578 572 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
We also tested receptor dimerization monitored as autophoshorylation of the receptor upon stimulation by the wild type FGF1 or its mutants. For this purpose, we employed confocal microscopy. U2OS cells stably transfected with FGFR1 were incubated for 15 min with wild type FGF1 or selected mutants in the presence or absence of heparin. Then the cells were fixed and stained for the early endosome antigen (EEA1; red) and phosphotyrosines reflecting activated receptor (green), and then co-localization of the two markers in vesicular structures was examined. As shown in Fig. 4, both for the wild type FGF1 and the mutants, there was no detectable difference in the co-localization of EEA1 and activated FGFR1 in the absence or presence of heparin.
###end p 62
###begin p 63
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Binding and internalization of FGF1 mutants.</bold>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pTyr</italic>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
Binding and internalization of FGF1 mutants. U2OS cells stably expressing FGFR1 were stimulated for 15 min with 100 ng/ml FGF1 or its selected variants in the presence or absence of heparin. Then the colocalization of EEA1 (red) and endocytosed FGFR1 (visualized by anti-phospho-Tyr (pTyr) antibody (green)) were examined by confocal microscopy.
###end p 63
###begin title 64
Activation of Downstream Signaling Cascades
###end title 64
###begin p 65
###xml 110 116 110 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 118 119 118 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
We next determined the ability of the mutants to activate the downstream signaling pathways in NIH 3T3 cells (Fig. 5, A and B, and ) and in U2OS cells stably transfected with FGFR1 (). We checked phosphorylation, reflecting the activation of FGFR as well as of MAPK, Akt, and p38 kinases and PLC-gamma upon short term stimulation with the growth factor. The activation was detected by immunoblotting using specific antibodies that recognize only the phosphorylated form of the proteins.
###end p 65
###begin p 66
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Activation of signaling cascades by wild type and mutants of FGF1 in the presence and absence of heparin.</bold>
###xml 221 222 221 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Activation of signaling cascades by wild type and mutants of FGF1 in the presence and absence of heparin. Serum-starved NIH 3T3 cells were treated with different concentrations of wild type FGF1 and its mutants (5 ng/ml (A) and 50 ng/ml (B)) for 15 min. To assay the activation of the downstream proteins, anti-phosphoprotein antibodies were used. To verify equal loading, stripped membranes were blotted with antibodies that recognized the total amount of each signaling protein.
###end p 66
###begin p 67
To assure equal loading of the gels, the membranes were reprobed with antibodies recognizing the total amount of the signaling proteins whether or not they were phosphorylated. In non-treated cells, we detected only weak basal phosphorylation of the signaling proteins tested.
###end p 67
###begin p 68
###xml 440 446 436 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 446 447 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
First, we tested the activation of the signaling cascades when the cells were treated with a low concentration (5 ng/ml) of FGF1. In the case of all (single and multiple) mutants with only one heparin-binding site mutated, there were no differences in FGFR stimulation and activation of the signaling pathways, as determined by monitoring the phosphorylation level of downstream kinases and PLC-gamma in the presence or absence of heparin (Fig. 5A and ). Single substitutions that lowered the affinity of FGF1 for heparin/HS had no effect on signal transduction as compared with the wild type, and the FGF1 mutants were functionally competent in activating signaling pathways even at a low concentration.
###end p 68
###begin p 69
###xml 181 187 181 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 517 523 517 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
However, at 5 ng/ml FGF1, the double substitution in the heparin-binding site (K112N/K118E) significantly altered the efficiency of activation of the downstream signaling proteins (Fig. 5A and ), lowering their phosphorylation level in accordance with the FGFR binding experiments. Next, we checked if it was possible to compensate for the lower heparin binding of the K112N/K118E mutants using a higher concentration of the growth factors, and we studied the activation of the signaling cascades with 50 ng/ml FGF1 (Fig. 5B and ). In this case, the phosphorylation of the receptor as well as the activation of all tested pathways was on the level of the wild type for all mutants.
###end p 69
###begin title 70
Mitogenic Activity of FGF1 Mutants
###end title 70
###begin p 71
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 938 939 938 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1002 1008 1002 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1008 1009 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1109 1115 1109 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1115 1116 1115 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
To check whether the inability to bind heparin can be compensated for by an increased stability of FGF1 with respect to its biological activities of the growth factor, we tested single and multiple mutants with reduced affinity for heparin and diverse stability for their mitogenic activity. Since the mitogenic potential of FGF1 is responsible for one of the crucial functions of the growth factor, stimulation of cell proliferation, we first checked the ability of the mutants to stimulate DNA synthesis in the presence and absence of heparin. This assay can be considered a long term response experiment, since it requires the survival of the growth factor in the medium for an extended period of time, over 12 h (44). Serum-starved NIH 3T3 cells were treated for 24 h with increasing concentrations of the wild type FGF1 or FGF1 mutants in the absence or presence of 10 units/ml heparin. Then the ability of the cells to incorporate [3H]thymidine during the last 6 h of the treatment was measured (Fig. 6A), and the specific mitogenic activity was calculated as described under "Experimental Procedures" (Fig. 6B).
###end p 71
###begin p 72
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mitogenic activity of wild type and mutants of FGF1.</bold>
###xml 52 53 52 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 274 275 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 342 344 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 351 353 349 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
Mitogenic activity of wild type and mutants of FGF1.A, normalized mitogenic activity curves derived from a [3H]thymidine incorporation experiment in NIH 3T3 cells in the presence or absence of heparin. The data shown are mean values of five independent experiments +/- S.D. B, relative mitogenic activity (in comparison with the wild type, EC50(WT)/EC50) of tested mutants in the presence and absence of heparin.
###end p 72
###begin p 73
###xml 137 143 137 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 172 178 172 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 178 179 178 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 181 188 181 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel I</italic>
###xml 848 854 848 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 854 855 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 857 864 857 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel I</italic>
All but one single mutant with disturbed heparin binding exhibited reduced ability to stimulate DNA synthesis in the presence of heparin versus that of the wild type FGF1 (Fig. 6A, panel I). The K112N variant, which demonstrated the highest thermodynamic stability among the single mutants, was as mitogenically potent as the wild type in the presence of heparin. On the other hand, the K118N mutant, which was the least stable one, was also the least efficient in stimulating thymidine incorporation. The next in the rank was the K118E mutant, which had the most severely reduced affinity for heparin. In contrast to the wild type and the mutants that exhibited less affected heparin binding (K112N, K112A, K112E, and K118A), we did not observe any difference in the mitogenic activity in the absence and presence of heparin for the K118E mutant (Fig. 6A, panel I). These results suggest that the significantly reduced ability of the growth factor to stimulate DNA synthesis could be mainly caused by the loss of the heparin protection.
###end p 73
###begin p 74
###xml 440 446 440 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 449 457 449 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel II</italic>
###xml 686 692 686 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 692 693 692 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 695 704 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel III</italic>
###xml 1058 1064 1058 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1064 1065 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1067 1075 1067 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">panel IV</italic>
To test this possibility, we constructed series of mutants containing the K112N and/or K118E mutations and stabilizing substitutions in different combinations. Introduction of the stabilizing mutations into the K118E variant compensated for the lack of heparin protection and recovered the ability of the growth factor to stimulate mitogenesis regardless of the presence of heparin at the level of the wild type in the presence of heparin (Fig. 6A, panel II). All of the mutants with the K118E substitution behaved similarly in the presence and absence of heparin. We also observed a similar effect for a series of FGF1 variants containing the K112N mutation in the absence of heparin (Fig. 6A, panel III). This single mutation did not reduce heparin affinity as strongly as the K118E substitution did. Nevertheless, the introduction of the stabilizing mutations was also able to improve the mitogenic potential of the K112N variant. We also tested mutants of different stability containing the double substitution (K112N/K118E) in the heparin-binding site (Fig. 6A, panel IV). These mutants exhibited strongly reduced affinity for heparin and could be considered as unable to bind to the cell surface heparans. All of them behaved similarly with respect to the mitogenic properties regardless of the presence of heparin. We also observed a stepwise effect of the stabilizing mutations on the mitogenic activity. However, even the most potent combination of stabilizing substitutions (Q40P, S47I, and H93G) could not elicit a mitogenic response comparable with that of the wild type FGF1 in the presence of heparin. The mutant 3x/K112N/K118E exhibited an approximately 5 times lower mitogenic activity than the wild type in the presence of heparin.
###end p 74
###begin p 75
A possible explanation of these data is that in the absence of heparin, cell surface heparans can still enable growth factor dimerization, despite the fact that they are not able to assure protection of FGF1. This is strongly supported by the behavior of the wild type FGF1 in the absence of heparin and its highly (but not completely) reduced mitogenic activity. For the mutants with the K112N/K118E substitution, even when they are very stable, the lack of affinity for heparans can change the kinetics of receptor binding. In such a case, higher concentrations of the growth factor are necessary to induce full mitogenic response.
###end p 75
###begin title 76
Proliferation of NIH 3T3 Cells in Response to Stimulation by FGF1 Mutants
###end title 76
###begin p 77
###xml 695 701 695 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
As shown above, we observed considerable differences in the mitogenic activity of FGF1 mutants with the same heparin affinity but different stability. To further investigate the effect of stabilizing mutations on the biological activity of FGF1, we studied the ability of selected FGF1 variants to induce proliferation of NIH 3T3 cells. The cells were incubated for 72 h with 100 ng/ml FGF1 in the presence or absence of heparin; therefore, such an experiment can be considered a long term response assay. We found that the mutants with higher stability exhibited a prolonged ability to stimulate proliferation as compared with wild type FGF1, even when they had a reduced affinity for heparin (Fig. 7). The effect was particularly significant in the absence of heparin. The wild type induced almost no cell proliferation without heparin as compared with the control (non-stimulated cells). Introduction of the stabilizing mutations gradually enhanced the ability of FGF1 to stimulate cell proliferation. The most active variant in this assay was the 3x/K112N mutant, which stimulated the proliferation of NIH 3T3 cells without heparin almost twice as effectively as the wild type in the absence of heparin. The second in the rank among the mutants tested in the proliferation test was the 3x/K112N/K118E mutant, which was very stable but had an extremely reduced affinity for heparin. In this case, similarly to the 3x/K118E mutant, the extent of cell proliferation induced 72 h after the addition of the growth factor was the same in the presence and absence of heparin. Once again, for K112N/K118E, 2x/K112N/K118E, and 3x/K112N/K118E mutants, a stepwise compensation of the stabilizing mutations for the protective effect of heparin was visible.
###end p 77
###begin p 78
###xml 0 50 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stimulation of cell proliferation by FGF1 mutants.</bold>
Stimulation of cell proliferation by FGF1 mutants. Serum-starved NIH 3T3 cells were treated with 100 ng/ml wild type or FGF1 mutant in the presence and absence of heparin. After 72 h, the number of cells was counted. Values are averages from three samples +/- S.D.
###end p 78
###begin title 79
Half-life of Mitogenic Activities
###end title 79
###begin p 80
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 661 662 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
As discussed earlier, an important aspect of FGF1 activity, which is strongly affected by the presence of heparin (or heparans), is the duration of the action of the growth factor. To assess this parameter, we calculated for selected mutants the half-life of the active protein (i.e. the time required for the loss of one-half of the initial biological activity) (29). The wild type and two series of mutants containing the K112N or K118E mutations and the stabilizing ones were incubated for different periods of time at 37 degreesC in serum-free medium in the presence or absence of heparin before being added to NIH 3T3 cells. Then a standard experiment of [3H]thymidine incorporation in the absence of heparin was performed, the specific mitogenic activities were calculated, and the half-life values were derived ().
###end p 80
###begin p 81
The activity of the K112N mutant was higher in the presence than in the absence of heparin. However, we did not observe such a tendency for the variants including the K118E substitution, considerably reducing the affinity of FGF1 to heparin. For these variants the data were similar irrespective of the presence of heparin.
###end p 81
###begin p 82
###xml 511 515 511 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 569 570 569 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 685 686 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All but one (the K118E) variants tested showed longer half-lives than the wild type when they were preincubated without heparin (). In contrast, in the presence of heparin, which protects the wild type against deactivation very effectively, only variants with the K112N mutation and the highly stable mutants with the K118E substitution exhibited longer half-life than the wild type (). The quadruple mutant 3x/K112N was the most resistant to deactivation, with a half-life over 36 h in the absence of heparin (i.e. more than 90-fold longer than that of the wild type (t(1/2) = 24 min)). Among the mutants with the K118E mutation, the 3x/K118E variant exhibited the longest half-life (t(1/2) = 10.5 h), being almost 30-fold more active than the wild type.
###end p 82
###begin title 83
Susceptibility of FGF1 Mutants to Proteolysis
###end title 83
###begin p 84
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 423 429 417 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
Our earlier study showed that the stabilizing mutations not only improved the thermodynamic stability of FGF1 but also increased its resistance to proteolytic degradation (29). To examine the relationship between proteolytic susceptibility, thermodynamic stability, and biological activity, we treated selected mutants with trypsin as a model protease at 37 degreesC. The proteolytic results obtained for the FGF1 mutants (Fig. 8) in the absence of heparin were in good agreement with the stability parameters reported in .
###end p 84
###begin p 85
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteolytic degradation of wild type and mutants of FGF1.</bold>
###xml 139 140 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 191 192 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 199 204 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrow</italic>
###xml 246 257 240 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">broken line</italic>
###xml 265 270 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">graph</italic>
###xml 327 332 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">graph</italic>
Proteolytic degradation of wild type and mutants of FGF1. Growth factors were digested at 37 degreesC by trypsin at a molar ratio of 1:80 (A) and 1:20 in the presence and absence of heparin (B). The arrow indicates the position of intact FGF1. A broken line on the graph corresponds to much higher values than presented on the graph, which cannot be determined correctly within experimental conditions.
###end p 85
###begin p 86
###xml 12 18 12 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 18 19 18 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 497 503 497 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
As shown in Fig. 8A, to digest wild type FGF1 completely, using trypsin at a molar ratio of 1:80, a period of 10 min was required, which corresponded to a protein half-life of slightly over 2.5 min. The mutant most susceptible to trypsin digestion was the K118N variant, which also exhibited the lowest denaturation temperature. The K112A, K112E, K118A, and K118E mutations did not seem to influence appreciably the susceptibility of FGF1 to proteolysis, similarly to its thermodynamic stability (Fig. 8A).
###end p 86
###begin p 87
###xml 924 930 924 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 930 931 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1174 1180 1174 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 1180 1181 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
The K112N and K112N/K118E mutants turned out to be more resistant to trypsin digestion than the wild type, and only after 30 min of incubation with the protease at a molar ratio 1:80 were they totally digested. As expected, introduction of the stabilizing mutations to the K112N and K118E variants increased gradually their resistance to enzymatic degradation in the absence of heparin. Combination of Q40P, S47I, and H93G substitutions dramatically slowed the proteolytic processing extending the protein half-life 15 times in the case of the 3x/K118E variant and over 25 times for the 3x/K112N mutant. We could observe a synergistic effect of the stabilizing mutations for the 2x/K112N/K118E and 3x/K112N/K118E variants, for which even after 1 h of trypsin digestion (at a molar ratio of 1:80) there was no distinct fragmentation, and the intensity of the band corresponding to the intact form of FGF1 remained unchanged (Fig. 8A). For a higher trypsin concentration (ratio of 1:20), all mutants demonstrated again a clear correlation between the conformational stability and resistance to protease action and a cumulative, protective effect of the stabilizing mutations (Fig. 8B).
###end p 87
###begin p 88
###xml 189 195 189 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 509 515 509 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
###xml 515 516 515 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
The presence of heparin strongly enhanced the resistance to proteolysis of the wild type and K112N FGF1, a mutant showing the least reduced heparin affinity of all of the analyzed mutants (Fig. 8B). For variants containing the K118E substitution, the presence of heparin only had a very slight enhancing effect on proteolytic resistance. Furthermore, all mutants with the both K118E and K112N substitutions had virtually identical protease susceptibility in the presence as well as in the absence of heparin (Fig. 8B). Because the binding of these mutants to heparin was strongly reduced, heparin did not exhibit any protective effect during the proteolytic degradation. This result fits very well with the thermodynamic data, since in the denaturation experiments, we observed a lack of protection by heparin during unfolding.
###end p 88
###begin title 89
In Vivo FGF1 Degradation
###end title 89
###begin p 90
###xml 8 15 8 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 325 331 319 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 331 332 325 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
To test in vivo the results obtained in the in vitro proteolytic digestion assay, we checked the processing of selected FGF1 mutants in NIH 3T3 cell culture at 37 degreesC. We analyzed the amount of the growth factor in the medium and in cell lysates at different time points during the 24 h after FGF1 addition. The data in Fig. 9A demonstrate that in the presence of heparin, the wild type growth factor remained intact in both fractions throughout the experiment. However, in the absence of heparin, the wild type was much more efficiently degraded than the mutants with reduced heparin binding but increased stability.
###end p 90
###begin p 91
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 0 99 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>In vivo</italic> degradation of wild type and selected mutants of FGF1 during incubation with NIH 3T3 cells.</bold>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrow</italic>
In vivo degradation of wild type and selected mutants of FGF1 during incubation with NIH 3T3 cells.A, presence of growth factors in medium and during the internalization process in cell lysates in the presence and absence of heparin. B, the effect of degradation inhibitors on extra- and intracellular processing of wild type FGF1 in the absence of heparin. The arrow indicates the position of intact FGF1.
###end p 91
###begin p 92
###xml 569 575 569 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
After 6 h of incubation with the cells without heparin, the wild type growth factor was only faintly seen in the medium, whereas the 3x/K118E mutant was only degraded to a slight extent, and the remaining mutants were intact even after 24 h. The lack of degradation of the 3x/K112N/K118E mutant confirms the protective effect of the K112N mutation. Similar results were obtained for the cell lysates in the absence of heparin. There was no evident reduction in the amount of the mutants, whereas the degradation of the wild type protein was clearly visible after 12 h (Fig. 9A).
###end p 92
###begin p 93
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We observed almost no difference in in vivo processing in the presence and absence of heparin for the mutants tested. These results indicate that the stabilizing mutations significantly reduce in vivo degradation, slowing the rate of FGF1 proteolysis within the cell and in the medium to a similar extent as does the presence of heparin toward the wild type FGF1.
###end p 93
###begin p 94
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 536 537 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 623 629 623 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">Fig. 9</xref>
###xml 629 630 629 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
To further elucidate the mechanism of intracellular processing of FGF1, we performed an in vivo degradation experiment for the wild type without heparin in the absence or presence of several protein degradation inhibitors. Preincubation with lactacystin, a proteasome degradation inhibitor, showed no effect on degradation of internalized FGF1 in NIH 3T3 cells. In contrast, reduced degradation of FGF1 was observed when cells were pretreated with lysosomal degradation inhibitors, such as leupeptin, bafilomycin A1, chloroquine, and NH4Cl, which prevent endosomal acidification required for activity of lysomal proteases (Fig. 9B). These data suggest that the degradation of endocytosed FGF1 is controlled by the lysosomal pathway and that proteasome is not required for this process. In the presence of the inhibitors, we also observed slight reduction of FGF1 degradation in the medium, which could be caused by the reduced amount of proteases released from the cell.
###end p 94
###begin p 95
The observed effect of inhibitors was similar to the effect of stabilizing mutations, suggesting that low stability of FGF1 makes the protein more susceptible to lysosomal degradation. This, again, confirms that increased stability protects FGF1 inside and outside the cell against proteolytic processing.
###end p 95
###begin title 96
Translocation of FGF Variants into Cells
###end title 96
###begin p 97
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
FGF1, similarly to FGF2, is able to cross the cellular membrane and to be translocated from the extracellular space into the cytosol and nucleus of target cells (33, 45). Therefore, we studied the ability of the mutants to enter the cells employing two previously described methods: in vivo phosphorylation of the externally added growth factor and digitonin fractionation of FGF1-treated cells (27, 40).
###end p 97
###begin p 98
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">118</sup>
###xml 539 542 539 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">112</sup>
The in vivo phosphorylation assay takes advantage of the fact that FGF1 contains a single functional phosphorylation site for protein kinase C, which is a cytosolic and nuclear enzyme. Therefore, cells are only able to phosphorylate the growth factor that has crossed the cell membrane. However, because one of the experimental steps requires binding to heparin-Sepharose and since Lys118 is part of the site recognized by protein kinase C, this assay could only be used with heparin-binding site mutants containing the substitution of Lys112.
###end p 98
###begin p 99
###xml 267 274 267 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
###xml 314 315 314 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">top</italic>
Serum-starved NIH 3T3 cells were incubated with FGF1 for 6 h in the presence of radioactive phosphate, and then the internalized growth factor was extracted from total cell lysates, run on SDS-PAGE, and electroblotted onto a membrane. FGF1 that had been radiolabeled in vivo was visualized by fluorography (Fig. 10A, top). The results clearly show that all of the variants containing a mutation at position 112 were effectively translocated into the cell, both in the presence and absence of heparin.
###end p 99
###begin p 100
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Translocation of wild type and mutants of FGF1 in the presence and absence of heparin.</bold>
###xml 246 253 246 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Translocation of wild type and mutants of FGF1 in the presence and absence of heparin. Serum-starved NIH 3T3 cells were incubated with 100 ng/ml growth factor in the presence of 10 units/ml heparin for 6 h, and the translocation was monitored by in vivo phosphorylation (A) and digitonin-based fractionation (B) assays.
###end p 100
###begin p 101
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bottom</italic>
Mutants with substitution at position 118, which is involved in the phosphorylation site for protein kinase C, served as negative controls. As a control of total cellular uptake of FGF1, we used immunodetection with anti-FGF1 antibody (Fig. 10A, bottom).
###end p 101
###begin p 102
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
To allow testing for the translocation of all of the mutants, we used a cell fractionation technique based on careful digitonin treatment of the cells under conditions where the plasma membrane is permeabilized while intracellular membranes remain intact (40, 46, 47). In this way, translocation of exogenously added FGF1 to the cytosol and nucleus can be monitored independently of its in vivo phosphorylation. NIH 3T3 cells were incubated with FGF1 variants for 6 h and then fractionated into cytosolic, nuclear, and membrane fractions, as described under "Experimental Procedures." The membrane fraction, which represents growth factor from intracellular vesicles, can be considered as a loading control. To verify the quality of the fractionation procedure, we analyzed lysates from each fraction using antibodies against marker proteins for different compartments (data not shown).
###end p 102
###begin p 103
###xml 107 114 107 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 340 347 340 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
Both in the presence and absence of heparin, all FGF1 mutants tested were detected in all three fractions (Fig. 10B). Interestingly, the wild type FGF1, which translocated nicely in the presence of heparin, was found neither in the cytosol nor in the nucleus in the absence of heparin, which was also seen using the phosphorylation method (Fig. 10, A and B). The presence of all of the mutants in the cytosolic and nuclear fractions indicates that reduced heparin binding not only does not disturb the translocation of the growth factor in the presence of heparin but also enables its entry into the cell in the absence of heparin.
###end p 103
###begin p 104
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
In all of these experiments, translocation of FGF1 to the cytosol and nucleus could be blocked by bafilomycin A1 (Fig. 10, A and B), which was used as a negative control. This compound prevents growth factor translocation due to inhibition of the vesicular proton pumps essential to generate the vesicular membrane electric potential required for the process (31, 32).
###end p 104
###begin title 105
DISCUSSION
###end title 105
###begin p 106
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 478 478 478 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15"/>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
Heparin and cell surface HS are considered to be important components of FGF-mediated signaling. The crystal structures of FGF1 and FGF2 complexes with FGFR solved in the presence of heparin clearly demonstrate its importance in complex formation (6, 20, 41, 48). Nevertheless, several reports question the direct requirement for heparin/HS in the assembly of a functional FGF.FGFR complex, stimulation of the signaling pathways, and generation of the mitogenic response (12, 14-16). Also, kinetic studies of FGF2.FGFR complex formation have revealed that in the presence of heparin, the dissociation rate constant is only 1 order of magnitude lower than in its absence (49).
###end p 106
###begin p 107
###xml 546 548 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 548 548 542 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18"/>
###xml 549 551 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 972 974 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1062 1063 1056 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1063 1066 1057 1060 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
In this study, we hypothesized that the main role of heparin is to protect FGF1 against heat and protease(s) under physiological conditions and that it is not required to form a functional FGF.FGFR complex. Free growth factor is a highly unstable protein with a denaturation temperature of about 40 degreesC at neutral pH, which means that a significant fraction of FGF1 is fully unfolded at physiological conditions and therefore prone to proteolysis. It is well documented that the addition of heparin effectively stabilizes the FGF1 molecule (17-19). Since the mitogenic potential of FGF1 is tested in assays taking at least 12 h, it is not clear whether the presence of heparin has a direct effect on the functional signaling complex or just a protective role. In our previous report, we showed that introduction of stabilizing mutation(s), either single or multiple, significantly improved the proteolytic resistance of free FGF1 and prolonged its biological action (29). Here, we applied the three most stabilizing mutations in combination, increasing the Tden of FGF1 by about 23 degreesC, to compensate for the absence of interaction with heparin, by providing the necessary protection against heat or protease(s).
###end p 107
###begin p 108
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 420 426 420 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 615 621 615 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 1047 1048 1047 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 1048 1051 1048 1051 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">den</sub>
###xml 1081 1087 1075 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
We studied the biological and biophysical properties of a series of 17 variants of FGF1: six single mutants (substituting lysines at position 112 or 118 responsible for heparin binding with Ala, Glu, or Asn), one double lysine mutant (K112N/K118E), and 10 multiple mutants carrying mutations at position 112 and/or 118 together with different combinations of the three stabilizing mutations (Q40P, S47I, and H93G) (29) (Fig. 1). All FGF1 variants comprising mutation(s) at the heparin binding site exhibited reduced affinity for immobilized heparin as probed by the elution profile from a heparin-Sepharose column (Fig. 2). A stepwise introduction of the stabilizing mutations in these variants did not affect the respective elution profiles, in agreement with the crystal structure of the Q40P/S47I/H93G variant, which shows that the global conformation and the heparin binding site are not affected in the triple mutant (50). As expected, in the case of all variants, the introduction of stabilizing mutations resulted in a significant shift in Tden values, up to 64.1 degreesC (Fig. 3).
###end p 108
###begin p 109
###xml 506 513 506 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 738 740 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
To verify the biological competence of the constructed mutants, we measured their activities in a series of experiments. Depending on the time scale of the test, we distinguish two classes of assays. In the short time response tests (time scale of minutes) we checked the ability of the mutants to bind to the receptor, activate it, and stimulate downstream signaling cascades. Long time response experiments (time scale of at least 12 h) included the stimulation of DNA synthesis, cell proliferation, and in vivo degradation. As shown earlier, sensitivity to heat denaturation and/or proteolysis can be revealed only in long time response experiments that are performed at 37 degreesC in cell culture containing extracellular proteases (29).
###end p 109
###begin p 110
###xml 321 328 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figs. 4</xref>
###xml 328 328 328 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5"/>
###xml 329 330 329 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
All of the mutants containing single substitutions that reduced heparin affinity (with or without the stabilizing mutations) showed no differences in competitive receptor binding, co-localization of phosphorylated receptors with early endosomes, and activation of FGF1 signaling pathways, as compared with the wild type (Figs. 4-6). These results indicate that none of the mutated residues are involved in the interactions with the high affinity receptor and that full short term activation of FGFR takes place even when the growth factor is defective in heparin binding.
###end p 110
###begin p 111
###xml 93 99 93 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 201 207 201 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 465 471 465 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
However, in the case of the K112N/K118E mutants, the most defective ones in heparin binding (Fig. 2), a reduced signaling activation was observed at a low concentration (5 ng/ml) of the growth factor (Fig. 5). As expected, this effect could be overcome by using a high concentration of the FGF1 mutants (50 ng/ml). In this case, there was no difference in the level of signaling between the mutants containing the double substitution K112N/K118E and the wild type (Fig. 5).
###end p 111
###begin p 112
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
For all variants, we tested the most crucial activity of the growth factor, its mitogenic potential. It was shown that a maximal mitogenic response requires the presence of a stable FGF1.FGFR complex over 12 h and that short term activation of the signaling pathways is not sufficient for stimulation of DNA synthesis by FGF1 (44, 51, 52). As is commonly done, we measured the ability of all of the mutants to stimulate cellular DNA synthesis after 24 h of incubation with the growth factor. All single mutants with reduced heparin affinity exhibited a significantly decreased ability to stimulate DNA synthesis. This could be due to the lack of protection of the growth factors provided by heparin and, in consequence, their higher susceptibility to proteases. Since we did not observe any difference in the activation of the signaling cascades in the case of the single mutants with reduced affinity for heparin, we concluded that the observed differences in the mitogenic potential of the variants were mainly due to differences in their stability and half-life.
###end p 112
###begin p 113
###xml 153 159 153 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 571 577 571 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
This view is supported by the findings that full mitogenic activity could be restored to the K118E and K112N mutants when their stability was increased (Fig. 6). Introduction of the stabilizing mutations protected the growth factor with reduced heparin affinity sufficiently to compensate for the deficiency in heparin binding and ensured the survival of the proteins for a long time. Also, in the case of mutants containing a double substitution in the heparin-binding site (K112N/K118E), we observed a stepwise effect of the stabilizing mutations on the DNA synthesis (Fig. 6).
###end p 113
###begin p 114
###xml 372 378 372 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
We also studied the effect of the heparin-binding site mutations in combination with the stabilizing substitutions on the ability of selected FGF1 variants to induce cell proliferation. In accordance with the effects on DNA synthesis, we found that increased stability provided prolonged ability to stimulate proliferation even when heparin affinity was strongly reduced (Fig. 7).
###end p 114
###begin p 115
###xml 170 178 170 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figs. 8</xref>
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F9">9</xref>
The compensating effect of the stabilizing mutations for the handicapped heparin protection was further demonstrated by testing the susceptibility of the FGF1 mutants to in vitro proteolysis and in vivo degradation (Figs. 8 and 9). The results of the trypsin digestion experiments were in excellent agreement with the thermodynamic stabilities and correlated nicely with the mitogenic activity assay and half-life experiments. This, again, confirms that the lack of mitogenic potential of the mutants with reduced heparin affinity reflects the lack of protection against heat/proteolysis and not their reduced functionality. We also observed that the degradation of endocytosed FGF1 was prevented by the lysosomal degradation inhibitors, which protect the growth factor in the absence of heparin to a similar extent as stabilizing mutations.
###end p 115
###begin p 116
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
Our data showing a positive mitogenic effect of mutational stabilization of the K118E (K132E) variant are consistent with the results published by Klingenberg et al. (28). They showed that the double mutant C131S/K132E, with a cysteine substitution increasing significantly the half-life of FGF1, showed a higher mitogenic activity than the single K132E mutant (28, 53). Also, a recent paper of Imamura and co-workers (54) revealed that in BaF3 cells lacking the capacity to synthesize glycosaminoglycans, an FGF1:FGF2 chimeric protein (FGFC) was able to activate FGFR and induce cell proliferation in the absence of heparin. Similarly to our constructs, FGFC was more stable and resistant to protease digestion than FGF1 (54).
###end p 116
###begin p 117
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 605 611 605 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1199 1201 1199 1201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 1363 1364 1363 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1241 1256 <span type="species:ncbi:10029">Chinese hamster</span>
Our results are also in good agreement with the many studies on FGF2 suggesting that, in the absence of heparin, active FGF2.FGFR complex can still be formed. Fannon and Nugent (12) found that in Balb/c3T3 cells lacking HS due to complete inhibition of proteoglycan sulfation, FGF2 was able to bind to the receptor, induce the signaling, and stimulate DNA synthesis in a dose-dependent manner. They clearly showed that HS worked by decreasing the rate of dissociation from FGFR but not altering the rate of FGF2 association and therefore had a stabilizing effect on the FGF2.FGFR complex. Also, Delehedde et al. (15, 16) showed that in sulfated glycosaminoglycan-deficient cells generated by sodium chlorate treatment, FGF2 was unable to stimulate DNA synthesis; however, it was able to trigger a transient phosphorylation of p42/44 MAPK. Finally, several other studies have reported heparin/HS-independent binding of FGF2 to its receptor, showing that the expression of early genes upon FGF2 stimulation is induced to the same extent in the presence and absence of heparin (14). It was also found that mutations in the heparin-binding region of FGF2 had no effect on its affinity for the receptor (55) and that in heparan sulfate-deficient Chinese hamster ovary 677 cells, FGF2 was not completely dependent on heparin/HS for activation of FGFR1 tyrosine kinase (7).
###end p 117
###begin p 118
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
The presented results are consistent with the symmetric "two-end" crystallographic model of FGF.FGFR interaction, which allows for receptor dimerization in the absence of heparin (48). In this model, heparin promotes coupling of two FGF.FGFR halves, but the formation of the FGF.FGFR dimer is dependent on protein-protein contacts (48).
###end p 118
###begin p 119
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 122 122 122 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57"/>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F10">Fig. 10</xref>
The presence of HS on the cell surface can affect the efficiency of receptor-mediated translocation of FGF1 into cells (56-58). Analysis of the cellular localization of wild type FGF1 and its mutants with reduced affinity for heparin showed striking differences in their behavior (Fig. 10). In the presence of heparin, wild type FGF1 and all of its variants were effectively translocated into the cell (to the cytosol and nucleus). However, in the absence of heparin, the wild type did not cross the cellular membrane barrier, in clear contrast to all of the mutants studied here.
###end p 119
###begin p 120
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
In the absence of heparin, wild type FGF1 binds to FGFR but also to the abundant heparan sulfates on the cell surface (17). Several reports show that in contrast to the binding of FGF1 to FGFR, its binding to cell surface heparans does not result in its functional translocation, instead directing the growth factor to the lysosome, where it is degraded (30, 58). The FGF1 mutants with low heparin affinity studied here can bind effectively only to FGFR and therefore can be efficiently translocated into the cytosol/nucleus. Because the affinity for heparin of wild type FGF1 is much higher than that for heparans, it seems that the increased level of heparin in specific stress conditions might be aiding efficient translocation of the growth factor. Such a mechanism may be important in regulating the intracellular fate of the growth factor. In this paper, we also confirmed that the translocation process is not influenced by FGF1 stability, which is in good agreement with our earlier studies. It was shown that stable, cross-linked FGF1 mutants were translocated to the cytosol and the nucleus equally well as the wild type FGF1 (46). On the other hand, we have reported that several mutants with decreased stability can also be effectively translocated across the cell membrane (34).
###end p 120
###begin p 121
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 546 548 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
Surface heparans may play an important regulatory role by creating a local reservoir of FGF1 (6, 17). Since the concentration of heparin in normal blood is very low, it is likely that any free growth factor tends to become bound to surface heparans on the cells close to the site of production, which prevents its diffusion far away. This can be crucial, since growth factors may have biological activities that should be limited to a defined location. An example is FGF8, which ensures correct localization of asymmetric organs and tissues (59, 60). The fact that the growth factor is very sensitive to proteolysis when not bound to heparin or heparans may be a backup system ensuring that runaway molecules are destroyed before they can act at a wrong location. We conclude that an increased stability of FGF1 can compensate for reduced heparin binding and that the main role of heparin/HS is to protect FGF1 against proteolytic degradation and in this way prolong the signal from the FGF.FGFR complex.
###end p 121
###begin title 122
Supplementary Material
###end title 122
###begin title 123
Supplemental Data
###end title 123
###begin p 124
This work was supported by Polish Ministry of Science and Higher Education Grant N N301 4192 33, by the Norwegian Cancer Society, by Raquel and Chr. Bruuns legat, and by Torsteds legat.
###end p 124
###begin p 125
The on-line version of this article (available at ) contains .
###end p 125
###begin p 126
###xml 28 32 28 32 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">FGFR</term>
###xml 32 65 32 65 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="127">fibroblast growth factor receptor</p>
###xml 32 65 32 65 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="127">fibroblast growth factor receptor</p></def>
###xml 28 65 28 65 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">FGFR</term><def><p textid="127">fibroblast growth factor receptor</p></def></def-item>
###xml 65 68 65 68 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">FGF</term>
###xml 68 92 68 92 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="128">fibroblast growth factor</p>
###xml 68 92 68 92 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="128">fibroblast growth factor</p></def>
###xml 65 92 65 92 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">FGF</term><def><p textid="128">fibroblast growth factor</p></def></def-item>
###xml 92 94 92 94 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">HS</term>
###xml 94 112 94 112 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="129">heparan sulfate(s)</p>
###xml 94 112 94 112 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="129">heparan sulfate(s)</p></def>
###xml 92 112 92 112 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">HS</term><def><p textid="129">heparan sulfate(s)</p></def></def-item>
###xml 112 116 112 116 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">MAPK</term>
###xml 116 148 116 148 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="130">mitogen-activated protein kinase</p>
###xml 116 148 116 148 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="130">mitogen-activated protein kinase</p></def>
###xml 112 148 112 148 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">MAPK</term><def><p textid="130">mitogen-activated protein kinase</p></def></def-item>
###xml 148 157 148 153 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">PLC-&#947;</term>
###xml 157 178 153 170 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="131">phospholipase C-&#947;</p>
###xml 157 178 153 170 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="131">phospholipase C-&#947;</p></def>
###xml 148 178 148 170 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">PLC-&#947;</term><def><p textid="131">phospholipase C-&#947;</p></def></def-item>
###xml 178 181 170 173 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">PBS</term>
###xml 181 206 173 198 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="132">phosphate-buffered saline</p>
###xml 181 206 173 198 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="132">phosphate-buffered saline</p></def>
###xml 178 206 170 198 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">PBS</term><def><p textid="132">phosphate-buffered saline</p></def></def-item>
###xml 206 208 198 200 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">2x</term>
###xml 208 230 200 222 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="133">substitution Q40P/S47I</p>
###xml 208 230 200 222 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="133">substitution Q40P/S47I</p></def>
###xml 206 230 198 222 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">2x</term><def><p textid="133">substitution Q40P/S47I</p></def></def-item>
###xml 230 232 222 224 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">3x</term>
###xml 232 259 224 251 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="134">substitution Q40P/S47I/H93G</p>
###xml 232 259 224 251 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="134">substitution Q40P/S47I/H93G</p></def>
###xml 230 259 222 251 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">3x</term><def><p textid="134">substitution Q40P/S47I/H93G</p></def></def-item>
###xml 259 261 251 253 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">WT</term>
###xml 261 271 253 263 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="135">wild type.</p>
###xml 261 271 253 263 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="135">wild type.</p></def>
###xml 259 271 251 263 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">WT</term><def><p textid="135">wild type.</p></def></def-item>
###xml 28 271 28 263 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">FGFR</term><def><p textid="127">fibroblast growth factor receptor</p></def></def-item><def-item><term id="G2">FGF</term><def><p textid="128">fibroblast growth factor</p></def></def-item><def-item><term id="G3">HS</term><def><p textid="129">heparan sulfate(s)</p></def></def-item><def-item><term id="G4">MAPK</term><def><p textid="130">mitogen-activated protein kinase</p></def></def-item><def-item><term id="G5">PLC-&#947;</term><def><p textid="131">phospholipase C-&#947;</p></def></def-item><def-item><term id="G6">PBS</term><def><p textid="132">phosphate-buffered saline</p></def></def-item><def-item><term id="G7">2x</term><def><p textid="133">substitution Q40P/S47I</p></def></def-item><def-item><term id="G8">3x</term><def><p textid="134">substitution Q40P/S47I/H93G</p></def></def-item><def-item><term id="G9">WT</term><def><p textid="135">wild type.</p></def></def-item></def-list>
The abbreviations used are: FGFRfibroblast growth factor receptorFGFfibroblast growth factorHSheparan sulfate(s)MAPKmitogen-activated protein kinasePLC-gammaphospholipase C-gammaPBSphosphate-buffered saline2xsubstitution Q40P/S47I3xsubstitution Q40P/S47I/H93GWTwild type.
###end p 126
###begin p 127
fibroblast growth factor receptor
###end p 127
###begin p 128
fibroblast growth factor
###end p 128
###begin p 129
heparan sulfate(s)
###end p 129
###begin p 130
mitogen-activated protein kinase
###end p 130
###begin p 131
phospholipase C-gamma
###end p 131
###begin p 132
phosphate-buffered saline
###end p 132
###begin p 133
substitution Q40P/S47I
###end p 133
###begin p 134
substitution Q40P/S47I/H93G
###end p 134
###begin p 135
wild type.
###end p 135
###begin title 136
Acknowledgment
###end title 136
###begin p 137
We are grateful to Ellen M. Haugsten for help with the confocal experiments.
###end p 137
###begin title 138
REFERENCES
###end title 138

